Literature DB >> 23674057

Microparticles prepared from biodegradable polyhydroxyalkanoates as matrix for encapsulation of cytostatic drug.

A V Murueva1, E I Shishatskaya, A M Kuzmina, T G Volova, A J Sinskey.   

Abstract

Microparticles made from degradable polyhydroxyalkanoates of different chemical compositions a homopolymer of 3-hydroxybutyric acid, copolymers of 3-hydroxybutyric and 4-hydroxybutyric acids (P3HB/4HB), 3-hydroxybutyric and 3-hydroxyvaleric acids (P3HB/3HV), 3-hydroxybutyric and 3-hydroxyhexanoic acids (P3HB/3HHx) were prepared using the solvent evaporation technique, from double emulsions. The study addresses the influence of the chemical compositions on the size and ξ-potential of microparticles. P3HB microparticles loaded with doxorubicin have been prepared and investigated. Their average diameter and ξ-potential have been found to be dependent upon the level of loading (1, 5, and 10 % of the polymer mass). Investigation of the in vitro drug release behavior showed that the total drug released from the microparticle into the medium increased with mass concentration of the drug. In this study mouse fibroblast NIH 3T3 cells were cultivated on PHA microparticles, and results of using fluorescent DAPI DNA stain, and MTT assay showed that microparticles prepared from PHAs of different chemical compositions did not exhibit cytotoxicity to cells cultured on them and proved to be highly biocompatible. Cell attachment and proliferation on PHA microparticles were similar to those on polystyrene. The cytostatic drug encapsulated in P3HB/3HV microparticles has been proven to be effective against HeLa tumor cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23674057     DOI: 10.1007/s10856-013-4941-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  23 in total

1.  Long-acting delivery microspheres of levo-norgestrol-poly(3-hydroxybutyrate): their preparation, characterization and contraceptive tests on mice.

Authors:  B Lu; Z R Wang; H Yang
Journal:  J Microencapsul       Date:  2001 Jan-Feb       Impact factor: 3.142

2.  Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.

Authors:  G Khang; S W Kim; J C Cho; J M Rhee; S C Yoon; H B Lee
Journal:  Biomed Mater Eng       Date:  2001       Impact factor: 1.300

3.  Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres.

Authors:  Haiyan Li; Jiang Chang
Journal:  J Control Release       Date:  2005-10-20       Impact factor: 9.776

4.  A hybrid PHB-hydroxyapatite composite for biomedical application: production, in vitro and in vivo investigation.

Authors:  E I Shishatskaya; I A Khlusov; T G Volova
Journal:  J Biomater Sci Polym Ed       Date:  2006       Impact factor: 3.517

5.  Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.

Authors:  Chan Zhang; Liangqi Zhao; Yuefeng Dong; Xiaoyan Zhang; Ji Lin; Zhang Chen
Journal:  Eur J Pharm Biopharm       Date:  2010-05-22       Impact factor: 5.571

6.  Sustained release of PI3K inhibitor from PHA nanoparticles and in vitro growth inhibition of cancer cell lines.

Authors:  Xiao-Yun Lu; Elisa Ciraolo; Rachele Stefenia; Guo-Qiang Chen; Yali Zhang; Emilio Hirsch
Journal:  Appl Microbiol Biotechnol       Date:  2011-02-01       Impact factor: 4.813

7.  Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.

Authors:  Berta Sanchez De Juan; Hagen Von Briesen; Svetlana E Gelperina; Jörg Kreuter
Journal:  J Drug Target       Date:  2006-11       Impact factor: 5.121

8.  DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin.

Authors:  Xiaoyun Cheng; Feng Zhang; Guangxin Zhou; Shuying Gao; Lei Dong; Wei Jiang; Zhi Ding; Jiangning Chen; Junfeng Zhang
Journal:  Drug Deliv       Date:  2009-04       Impact factor: 6.419

9.  Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending.

Authors:  J K Embleton; B J Tighe
Journal:  J Microencapsul       Date:  1993 Jul-Sep       Impact factor: 3.142

10.  Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats.

Authors:  M A Salman; A Sahin; M A Onur; K Oge; A Kassab; U Aypar
Journal:  Acta Anaesthesiol Scand       Date:  2003-09       Impact factor: 2.105

View more
  6 in total

1.  Development and characterization of bio-derived polyhydroxyalkanoate nanoparticles as a delivery system for hydrophobic photodynamic therapy agents.

Authors:  Sasivimon Pramual; Apinya Assavanig; Magnus Bergkvist; Carl A Batt; Panya Sunintaboon; Kriengsak Lirdprapamongkol; Jisnuson Svasti; Nuttawee Niamsiri
Journal:  J Mater Sci Mater Med       Date:  2015-12-28       Impact factor: 3.896

2.  Polyenes in Medium Chain Length Polyhydroxyalkanoate (mcl-PHA) Biopolymer Microspheres with Reduced Toxicity and Improved Therapeutic Effect against Candida Infection in Zebrafish Model.

Authors:  Aleksandar Pavic; Zoran Stojanovic; Marina Pekmezovic; Đorđe Veljović; Kevin O'Connor; Ivana Malagurski; Jasmina Nikodinovic-Runic
Journal:  Pharmaceutics       Date:  2022-03-24       Impact factor: 6.525

3.  Experimental wound dressings of degradable PHA for skin defect repair.

Authors:  Ekaterina I Shishatskaya; Elena D Nikolaeva; Olga N Vinogradova; Tatiana G Volova
Journal:  J Mater Sci Mater Med       Date:  2016-09-21       Impact factor: 3.896

4.  Polyhydroxyalkanoates-Based Nanoparticles as Essential Oil Carriers.

Authors:  Iolanda Corrado; Rocco Di Girolamo; Carlos Regalado-González; Cinzia Pezzella
Journal:  Polymers (Basel)       Date:  2022-01-01       Impact factor: 4.329

5.  Poly(3-hydroxybutyrate)/poly(amine)-coated nickel oxide nanoparticles for norfloxacin delivery: antibacterial and cytotoxicity efficiency.

Authors:  Nehal Salahuddin; Mohamed Gaber; Maie Mousa; Mohamed A Abdelwahab
Journal:  RSC Adv       Date:  2020-09-17       Impact factor: 4.036

6.  Vimentin Cytoskeleton Architecture Analysis on Polylactide and Polyhydroxyoctanoate Substrates for Cell Culturing.

Authors:  Karolina Feliksiak; Daria Solarz; Maciej Guzik; Aneta Zima; Zenon Rajfur; Tomasz Witko
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.